Searchable abstracts of presentations at key conferences in endocrinology

ea0056p166 | Bone ' Osteoporosis | ECE2018

A case report: FGF23-related tumor-induced osteomalacia in a patient with pulmonary adenocarcinoma

Arai Hiroshi , Kanai Yugo , Nakamoto Yuji , Nagai Hiroki , Sakamori Yuichi , Yasoda Akihiro , Inagaki Nobuya

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by the abnormal production of fibroblast growth factor 23 (FGF23) in the tumor. Here we report a case of TIO with pulmonary adenocarcinoma. A 61-year old woman was referred to our hospital. She was suffering from severe polyarthralgia and bilateral limb weakness. Her blood chemistry revealed high alkaline phosphatase, low phosphate, low calcium, and low 1,25-(OH)2D3. Bone-scintigrap...

ea0070aep198 | Bone and Calcium | ECE2020

Follow-up report: A case of FGF23-related tumor-induced osteomalacia with pulmonary adenocarcinoma

Arai Hiroshi , Kanai Yugo , Nakamoto Yuji , Sakamori Yuichi , Yamauchi Ichiro , Fujii Toshihito , Taura Daisuke , Sone Masakatsu , Yasoda Akihiro , Inagaki Nobuya

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by the abnormal production of fibroblast growth factor 23 (FGF23) in the tumor. We havereported a case of TIO with pulmonary adenocarcinoma at ECE2018. Here we present the follow-up report of the case. A 61-year old woman suffering from severe polyarthralgia and bilateral limb weakness was referred to our hospital. Her blood chemistry revealed high alkaline phosphatase, low phosphate, low calcium, and lo...